Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
crsp
/
CRISPR Therapeutics AG
CRSP
Add to Watchlist
47.640
USD
+0.090
+0.19%
Close 07-29 16:00(ET)
Quotes delayed by 15 min
47.650
USD
+47.650
After-hours 07/30, 20:00 (ET)
4.59B
Market Cap
Loss
P/E TTM
CRISPR Therapeutics AG
47.640
+0.090
+0.19%
Overview
Financials
Discussions
Analysis
Company
Profile
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Shareholders
Corporate
Shareholding Stats
Updated: Mon, May 11
Updated: Mon, May 11
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
ARK Investment Management LLC
11.73%
BlackRock Institutional Trust Company, N.A.
6.92%
Orbis Investment Management Ltd.
6.17%
State Street Investment Management (US)
3.89%
T. Rowe Price Investment Management, Inc.
3.35%
Other
67.95%
Shareholders
Shareholders
Proportion
ARK Investment Management LLC
11.73%
BlackRock Institutional Trust Company, N.A.
6.92%
Orbis Investment Management Ltd.
6.17%
State Street Investment Management (US)
3.89%
T. Rowe Price Investment Management, Inc.
3.35%
Other
67.95%
Shareholder Types
Shareholders
Proportion
Investment Advisor
40.10%
Investment Advisor/Hedge Fund
23.67%
Venture Capital
3.37%
Corporation
3.34%
Individual Investor
2.56%
Research Firm
2.41%
Hedge Fund
1.29%
Bank and Trust
0.64%
Sovereign Wealth Fund
0.51%
Other
22.12%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
1020
75.38M
78.16%
-5.90M
2025Q4
980
79.52M
84.90%
+75.16K
2025Q3
1019
79.46M
89.59%
+5.57M
2025Q2
986
73.90M
82.20%
+7.69M
2025Q1
943
66.36M
83.61%
-5.70M
2024Q4
951
66.15M
80.53%
+2.60M
2024Q3
955
62.43M
76.50%
+840.55K
2024Q2
969
61.63M
76.06%
+573.40K
2024Q1
979
61.11M
68.18%
+3.34M
2023Q4
980
54.61M
75.07%
+613.05K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
ARK Investment Management LLC
10.52M
10.96%
+735.08K
+7.51%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
6.67M
6.95%
+424.08K
+6.79%
Dec 31, 2025
Orbis Investment Management Ltd.
5.95M
6.2%
+968.06K
+19.43%
Dec 31, 2025
State Street Investment Management (US)
3.75M
3.91%
-253.79K
-6.33%
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
3.23M
3.36%
-55.99K
-1.71%
Dec 31, 2025
GSK plc
3.22M
3.36%
+3.22M
--
Dec 31, 2025
Geode Capital Management, L.L.C.
2.25M
2.34%
+108.05K
+5.05%
Dec 31, 2025
George (Simeon J.)
1.05M
1.09%
--
--
Mar 15, 2025
SR One Capital Management, LP
2.04M
2.12%
--
--
Dec 31, 2025
Fidelity Management & Research Company LLC
1.95M
2.04%
+68.29K
+3.62%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
ARK Genomic Revolution ETF
10.33%
Global X Genomics & Biotechnology ETF
5.71%
ARK Innovation ETF
5.12%
AXS Green Alpha ETF
4.84%
WisdomTree BioRevolution Fund
2.81%
Virtus LifeSci Biotech Products ETF
2.48%
State Street SPDR S&P Biotech ETF
2.41%
Direxion Daily S&P Biotech Bull 3X Shares
1.48%
Franklin Genomic Advancements ETF
0.92%
ProShares Ultra Nasdaq Biotechnology
0.59%
View more
ARK Genomic Revolution ETF
Proportion
10.33%
Global X Genomics & Biotechnology ETF
Proportion
5.71%
ARK Innovation ETF
Proportion
5.12%
AXS Green Alpha ETF
Proportion
4.84%
WisdomTree BioRevolution Fund
Proportion
2.81%
Virtus LifeSci Biotech Products ETF
Proportion
2.48%
State Street SPDR S&P Biotech ETF
Proportion
2.41%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion
1.48%
Franklin Genomic Advancements ETF
Proportion
0.92%
ProShares Ultra Nasdaq Biotechnology
Proportion
0.59%